Results 131 to 140 of about 101,368 (155)

Abstracts From the 49th Congress of the International Society of Paediatric Oncology (SIOP) Washington, DC, USA October 12-15, 2017. [PDF]

Pediatr Blood Cancer, 2017
europepmc   +1 more source

Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces

Acta Pharmaceutica Sinica B, 2016
Ginsenoside Rg1 (Rg1), the major effective component of ginseng, has been shown to have multiple bioactivities, but low oral bioavailability. The aim of this study was to develop a simple, sensitive and rapid high performance liquid chromatography–tandem
Nai-Hong Chen, Min Huang
exaly   +2 more sources

Ginsenoside Rg1 Epigenetically Modulates Smad7 Expression in Liver Fibrosis via MicroRNA-152

Journal of Ginseng Research, 2023
Background: Ginsenoside Rg1, a bioactive component of Ginseng, has demonstrated anti-inflammatory, anti-cancer, and hepatoprotective effects. It is known that the epithelial–mesenchymal transition (EMT) plays a key role in the activation of hepatic ...
Jianjian Zheng, Chunxue Li, Yating Zhan   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases

Cells, 2022
Nai-Hong Chen, Qidi Ai, Fan Yi
exaly  

Ginsenoside Rg1 ameliorates Alzheimer's disease pathology via restoring mitophagy

Journal of Ginseng Research, 2023
Zhong Li, Shunjie Liu
exaly  

Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation

Phytomedicine, 2021
Zhiping Lv, Sha Huang
exaly